TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 18 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $150,000 | -86.6% | 254,330 | -11.5% | 0.00% | -100.0% |
| Q2 2018 | $1,122,000 | +246.3% | 287,300 | +166.0% | 0.00% | – |
| Q1 2018 | $324,000 | +25.6% | 108,000 | +44.4% | 0.00% | – |
| Q4 2017 | $258,000 | +44.1% | 74,800 | +90.8% | 0.00% | – |
| Q3 2017 | $179,000 | -20.4% | 39,200 | -18.6% | 0.00% | – |
| Q1 2017 | $225,000 | – | 48,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Financial, Inc. | 281,626 | $1,284,000 | 0.35% |
| Nine Chapters Capital Management LLC | 19,600 | $89,000 | 0.20% |
| Baker Brothers Advisors | 699,500 | $3,190,000 | 0.03% |
| A.R.T. Advisors, LLC | 42,092 | $191,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 8,800 | $40,000 | 0.00% |
| Virtu Financial LLC | 12,320 | $56,000 | 0.00% |
| OPPENHEIMER & CO INC | 13,500 | $62,000 | 0.00% |
| GLENMEDE TRUST CO NA | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 20,121 | $92,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 400 | $2,000 | 0.00% |